Le Lézard
Classified in: Health
Subjects: AVO, CPG, DEI

AQPSUD's involvement in the National Day of Action Against Overdose


MONTREAL, April 18, 2024 /CNW/ - TIOHTIA:KE - As part of the National Day of Action Against Overdose on Thursday, April 18, the Association Québécoise pour la promotion de la santé des personnes utilisrices de drogues (AQPSUD) calls on the government authorities concerned to immediately review drug policies in Quebec. In the face of a growing overdose crisis, it is critical that we take concrete action without delay.

Today, AQPSUD is putting forward a series of urgent requests. We have seen the failure of prohibition, which tragically cost the lives of 17,600 Canadians from 2016 to 2020. In response, we call for greater access to safer substances and emphasize the need for a legal and regulated system to ensure the safety and autonomy of those who use these substances.

We also call for urgent funding to develop universally available antidotes such as benzodiazepines and xylazine. Given the alarming increase in the number of overdoses in Quebec, we support the decriminalization of drug possession, a measure that could reduce the number of deaths, improve access to services and combat the stigmatization of people who use drugs.

We also call for easier access to supervised consumption services (SCS) and the development of inhalation rooms, both of which are essential to reducing overdose mortality and health risks. Finally, we advocate for continued access to substance testing services and an end to all forms of stigmatization of people who use drugs.

AQPSUD makes an urgent appeal to governments, institutions and all relevant sectors of society. Your support and participation in this day of action is essential to making meaningful changes in the lives of people who use drugs. Together we can combat the overdose crisis and improve the health and well-being of those around us. We thank you for your attention and look forward to your active support for this important cause.

Across Quebec, allies are mobilizing today to demand changes in our policies.

dossierdepresseJACS2024-4.pdf (aqpsud.org)

https://www.facebook.com/AQPSUD

SOURCE AQPSUD


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: